Side Effects & Safety Mild GI discomfort most common, usually transient in the first week Slight stimulant effect increased energy/alertness, especially early on Headaches occasional, typically mild and dose-related Mild insomnia if taken too late in the day No human clinical safety data all safety information from preclinical studies and community reports No liver toxicity observed in animal studies at therapeutic doses Unknown drug interactions theoretically could interact with NAD+-dependent pathways Core Supplies for This Protocol The essentials for running any reconstituted injectable: cold storage, accurate syringes, alcohol prep pads, and metabolic tracking
How quickly will I see results
Secondary applications with emerging evidence include wound healing in patients with non-healing tissue, hair follicle stimulation, and early-stage research into cardiac recovery effects following the 2026 human trial data on Thymosin Beta-4
The biggest mistake I see is stopping the protocol as soon as symptoms improve
The depletion of glutathione (an antioxidant needed to remove the cyanide from cyano B12) may increase homocysteine, thus only making things worse for these patients
BPC-157 10mg Research-grade BPC-157 (Body Protection Compound-157), a synthetic 15-amino-acid pentadecapeptide derived from gastric juice proteins